Interleukin 25 regulates type 2 cytokine-dependent immunity and limits chronic inflammation in the gastrointestinal tract by Owyang, Alexander M. et al.
T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e
BRIEF DEFINITIVE REPORT
JEM © The Rockefeller University Press  $8.00
Vol. 203, No. 4,  April 17, 2006  843–849  www.jem.org/cgi/doi/10.1084/jem.20051496
843
CD4+ T helper 2 (TH2) cells that produce the 
cytokines IL-4, IL-5, IL-9, and IL-13 medi-
ate type 2 immunity by activating innate and 
adaptive components of the immune response
(1–3). Type 2 immune responses are thought 
to have evolved primarily to control pathogen
invasion at mucosal sites and are required 
for the development of resistance to helmi  nth 
infections. However, dysregulated type 2 re-
sponses to environmental antigens can result in 
severe pathological states such as asthma and 
  allergic infl  ammation, conditions that   aff  ect an 
  estimated 15–30% of the United States pop-
ulation (4, 5). Understanding the factors that 
regulate type 2 immunity and infl  ammation is 
a critical   aspect of developing novel   approaches 
to treat these debilitating infections and infl  am-
matory diseases.
IL-25 (IL-17E) is a recently described mem-
ber of the IL-17 cytokine gene family (6–8). 
IL-25 is produced by activated TH2 cells and 
mast cells and signals through the IL-25 R (IL-
17Rh1 or IL-17BR), a single pass transmem-
brane receptor that is expressed in the kidneys, 
liver, intestine, and on dendritic cells activated 
in the presence of TH2 cytokines (9–13). 
  Administration of exogenous IL-25 has been 
shown to induce the expression of IL-5 and 
IL-13 by an accessory cell population and has 
been suggested to be involved in the initiation 
and amplifi  cation of type 2 responses (11). 
However, whether IL-25 plays any role in the 
regulation of immunity and infl  ammation in vivo 
is unknown.
Infection of mice with the helminth Trichuris 
muris is a well-defi  ned model system to study 
the cellular and molecular requirements of type 
2 immunity in the gastrointestinal (GI) tract. 
Resistance to infection (e.g., in BALB/c or 
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The cytokine interleukin (IL) 25 has been implicated in the initiation of type 2 immunity by 
driving the expression of type 2 cytokines such as IL-5 and IL-13, although its role in the 
regulation of immunity and infection-induced infl  ammation is unknown. Here, we identify 
a dual function for IL-25: fi  rst, in promoting type 2 cytokine-dependent immunity to 
gastrointestinal helminth infection and, second, in limiting proinfl  ammatory cytokine 
production and chronic intestinal infl  ammation. Treatment of genetically susceptible mice 
with exogenous IL-25 promoted type 2 cytokine responses and immunity to Trichuris. IL-25 
was constitutively expressed by CD4+ and CD8+ T cells in the gut of mouse strains that are 
resistant to Trichuris, and IL-25–defi  cient mice on a genetically resistant background failed 
to develop a type 2 immune response or eradicate infection. Furthermore, chronically 
infected IL-25−/− mice developed severe infection-induced intestinal infl  ammation associ-
ated with heightened expression of interferon-𝗄 and IL-17, identifying a role for IL-25 
in limiting pathologic infl  ammation at mucosal sites. Therefore, IL-25 is not only a critical 
mediator of type 2 immunity, but is also required for the regulation of infl  ammation in the 
gastrointestinal tract.
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C57BL/6 mice) is associated with the hallmarks of type 2 
  immunity: outgrowth of antigen-specifi  c CD4+ TH2 cells that
produce IL-4 and IL-13, mastocytosis, IgG1 and IgE pro-
duction, goblet cell hyperplasia, and production of RELMβ, 
which is a novel goblet cell-specifi  c protein associated with 
immunity to helminth parasites (14–18). In contrast, CD4+ 
TH1 cells that produce IFN-γ promote parasite persistence, 
resulting in chronic infection (e.g., in AKR mice). Most sus-
ceptible strains of mice that harbor persistent parasites exhibit 
moderate infection-induced pathology, whereas strains defi  -
cient in IL-10 or NFκB1 develop severe intestinal infl  am-
mation that can lead to death (19, 20). Thus, infection with 
Trichuris provides a tractable system to study immunity and 
  infl  ammation in the GI tract. Here, we provide evidence that 
IL-25 is a critical cytokine in both promoting type 2 cytokine-
dependent resistance to Trichuris infection and in inhibiting 
destructive intestinal infl  ammation.
RESULTS AND D  I  S  C  U  S  S  I  O  N 
To test whether IL-25 could induce a protective type 2 
response and confer immunity to Trichuris in a normally 
susceptible strain, infected AKR mice were treated with re-
combinant IL-25 (rIL-25). Although control-treated mice 
exhibited a polarized Trichuris-specifi  c  IFN-γ response in 
the absence of detectable IL-4 (Fig. 1 A), administration of 
rIL-25 resulted in the induction of an antigen-specifi  c IL-4 
response and extinguished IFN-γ production (Fig. 1 A). In 
addition, rIL-25–treated AKR mice exhibited the hallmarks 
of a protective TH2 cell response, including reduced levels 
of Trichuris-specifi  c IgG2a (Fig. S1, available at http://www.
jem.org/cgi/content/full/jem.20051496/DC1), an increase 
in the numbers of goblet cells in the cecum (Fig. 1 B) and 
increased   expression of RELMβ (Fig. 1 C). Consistent with 
the development of a Trichuris-specifi  c type 2 response, 
rIL-25 treatment conferred resistance to infection, as untreated 
AKR mice had a high parasite burden, whereas treated AKR 
mice achieved sterile cure (Fig. 1 D). IL-25–induced im-
munity was lymphocyte dependent, as infected SCID mice 
treated with rIL-25 did not exhibit goblet cell responses 
(Fig. 1 B) and were unable to eradicate infection (Fig. 1 D). 
Thus, exogenous IL-25 can promote protective lymphocyte-
  dependent type 2 responses and act as an eff  ective therapeutic 
treatment to enhance type 2 immunity in the GI tract.
We next tested whether early diff  erences in expression of 
IL-25 was a predictor of infection outcome in genetically 
  resistant versus susceptible strains. Although no infection-
  induced increases in IL-25 mRNA were observed after infec-
tion with Trichuris (unpublished data), we found that resistant 
BALB/c mice expressed constitutively higher levels of IL-25 
mRNA in the cecum but not the mesenteric lymph node 
(mLN) compared with susceptible AKR mice, whereas both 
strains expressed equivalent but low levels of IL-25 mRNA 
in the mLN (Fig. 2 A). Furthermore, IL-25 receptor (IL-25R) 
mRNA expression by BALB/c mice was elevated in both 
compartments (Fig. 2 A). To determine the cellular source 
of IL-25, we examined the expression of a lacZ reporter 
  construct inserted into the IL-25 locus. This reporter system 
  allows for the amplifi  cation of the endogenous IL-25 re-
sponse by using the fl  uorescent  β-galactosidase substrate, 
FDG. Upon examination of the mLN and cecal patch (CP) 
Figure 1.  Exogenous IL-25 promotes immunity to Trichuris in 
  genetically susceptible AKR mice. AKR mice were infected with Trichuris 
and treated with PBS or rIL-25 intraperitoneally every other day from 
days 8–18. (A) IL-25 induces a protective TH2 cytokine response. Antigen-
specifi  c IFN-γ and IL-4 production from restimulated mLN cells was 
  determined by ELISA. White bars, medium; black bars, Trichuris antigen. 
(B) IL-25 promotes lymphocyte-dependent goblet cell responses. Cecal 
sections from day 20 infected AKR or SCID mice with or without rIL-25 
treatment were stained for goblet cells. Bar, 50 μm. (C) IL-25 induces 
RELMβ production after infection with Trichuris. RELMβ levels were 
  determined by immunoblotting of protein isolated from fecal pellets 
  isolated from infected mice at days 14 and 17 after infection. (D) IL-25 
promotes resistance to infection with Trichuris. Worm burdens from 
  infected AKR or SCID mice with or without rIL-25 treatment were 
  determined at day 20 after infection. Results are presented as mean 
± SEM and are representative of three independent experiments with 
three to four mice per group. ND, not detected. *, P < 0.01.JEM VOL. 203, April 17, 2006  845
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(the murine equivalent of the appendix) for expression of 
the lacZ/IL-25, we identifi  ed that populations of CD4+ and 
CD8+ T cells residing specifi  cally in the CP of naive mice 
expressed β-galactosidase activity (Fig. 2 B). We observed 
no FDG staining in CD19+, FcεRI+, CCR3+, NK1.1+, 
CD11c+, or CD11b+ cells from the mLN or CP (unpub-
lished data). Thus, IL-25 is constitutively expressed by a sub-
set of T cells that are found in the CP of resistant mice.
To directly investigate the functional signifi  cance  of 
  endogenous IL-25 in the development of protective type 2 
cytokine responses in the GI tract, IL-25−/− mice were gen-
erated by homologous recombination and infected with 
Trichuris. IL-25−/− mice on a C57BL/6 genetic background 
were born in expected Mendelian ratios, developed nor-
mally, and exhibited no defects in lymphocyte development 
in the thymus and periphery (unpublished data). After infec-
tion, WT mice exhibited enhanced expression of IL-4 and 
IL-13 mRNA in the draining mLN and elevated IL-4 
mRNA levels in the cecum at day 20 after infection with a 
negligible increase in IFN-γ mRNA expression at both sites 
(Fig. 3 A). In contrast, IL-4 and IL-13 mRNA levels were 
signifi  cantly reduced in infected IL-25−/− mice with a coin-
cident elevation of IFN-γ mRNA levels (Fig. 3 A). Levels of 
secreted cytokine protein after antigen restimulation of mLN 
cells were consistent with ex vivo mRNA levels (unpub-
lished data). The mRNA of other cytokines implicated in 
resistance to Trichuris, including TNF-α (21) and IL-1β (22), 
were not expressed at signifi  cantly  diff   erent levels in the 
mLN between WT and IL-25−/− mice (unpublished data). 
IL-25−/− mice also exhibited lower serum levels of Trichuris-
specifi  c IgG1 (Fig. S2 A, available at http://www.jem.org/cgi/
content/full/jem.20051496/DC1) and total IgE (Fig. S2 B), 
and elevated levels of Trichuris-specifi  c IgG2a (Fig. S2 A), 
further refl  ecting a shift from a protective type 2 response to 
a nonprotective type 1 response in the absence of IL-25. 
  Infection of WT mice with Trichuris resulted in increased 
numbers of goblet cells in the cecum (Fig. 3 B) and elevated 
secretion of RELMβ into the GI lumen (Fig. 3 C). In con-
trast, infected IL-25−/− mice failed to exhibit any signifi  cant 
goblet cell hyperplasia (Fig. 3 B) or detectable secretion of 
Figure 2.  IL-25 is expressed constitutively in the cecal patch of 
mice resistant to Trichuris. (A) Increased expression of IL-25 and IL-25R 
mRNA in the cecum of resistant BALB/c (B/c) mice. IL-25 and IL-25R 
mRNA levels were determined by real-time PCR from the cecum or mLN 
of naive BALB/c or AKR mice. (B) CD4+ and CD8+ T cells in the cecal patch 
express lacZ/IL-25. Cells from the mLN or cecal patch of IL-25−/− mice 
were stained with FDG and CD4 or CD8. Numbers represent frequency of 
FDG+ CD4+ or CD8+ T cells. Data are representative of three to four 
  independent experiments with three to four mice per group.
Figure 3.  Endogenous IL-25 is required for resistance to Trichuris. 
(A) IL-25 is required for optimal production of TH2 cytokines after infection. 
IL-4, IL-13, and IFN-γ expression in the mLN and cecum in WT and 
IL-25−/− mice at day 18 after infection as measured by real-time PCR. 
(B) Defective goblet cell responses in IL-25−/− mice after infection with 
  Trichuris. Cecal sections from day 18 infected WT or IL-25−/− mice were 
stained for goblet cells. Bar, 50 μm. (C) IL-25−/− mice fail to up-regulate 
RELMβ after infection. Protein isolated from fecal pellets on various days 
after infection was analyzed by SDS-PAGE and immunoblotted for 
RELMβ. (D) IL-25 is required for resistance to infection with Trichuris. 
Worm burdens in WT, IL-25−/− and RAG−/− mice at day 30 after infection. 
Data are presented as mean ± SEM and are representative of four 
  independent experiments with three to four mice per group. N, naive; 
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RELMβ (Fig. 3 C). Interestingly, mucosal mast cell responses 
(numbers of mast cells in the gut and serum levels of mouse 
mast cell protease-1) that are also associated with type 2 
  responses at mucosal sites (14, 23) were unimpaired in the 
absence of IL-25 (Fig. S3, A and B, available at http://www.
jem.org/cgi/content/full/jem.20051496/DC1), demonstrating 
that IL-25 diff  erentially regulates specifi  c components of 
type 2 cytokine-dependent infl  ammation in the GI tract. 
Nevertheless, consistent with a defective type 2 immune 
  response, IL-25−/− mice were unable to eradicate infection 
and were as susceptible as RAG-defi  cient mice, whereas WT 
mice were resistant to infection, clearing worms by day 20 
after infection (Fig. 3 D). Thus, endogenous IL-25 is a criti-
cal component of type 2 cytokine-dependent immunity in 
the GI microenvironment.
Although the cytokines that drive TH1 cell diff  erentiation 
and type 1 infl  ammation are well characterized, the factors 
that promote the development of type 2 responses in vivo 
  remain elusive (24). Based on higher levels of IL-25/IL-25R 
mRNA in genetically resistant mouse strains, coupled with 
the results demonstrating that exogenous IL-25 can drive 
  expression of TH2 cytokines, whereas type 2 immunity is 
  severely impaired in IL-25−/− mice, we hypothesized that 
this cytokine may be the critical factor required for the devel-
opment of TH2 cells and type 2 responses in vivo. To test 
whether IL-25 expression was essential for immunity to 
Trichuris, infected IL-25−/− mice were treated with a combi-
nation of anti–IL-12 and anti–IFN-γ monoclonal antibodies. 
Previous studies have shown that in vivo depletion of type 1 
cytokines can promote type 2 cytokine-dependent resistance 
to Trichuris in normally susceptible hosts (16, 19). Blockade 
of type 1 cytokines in infected IL-25−/− mice was associated 
with elevated production of Trichuris-specifi  c IL-4, IL-5, and 
IL-13 in the draining mLN (Fig. 4 A), enhanced serum IgE 
responses (Fig. S4 A, available at http://www.jem.org/cgi/
content/full/jem.20051496/DC1), and a recovery of intes-
tinal goblet cell responses (Fig. 4 B). Furthermore, anti–IL-12/
anti–IFN-γ treated IL-25−/− mice exhibited reduced Trichuris-
specifi  c IFN-γ production (Fig. 4 A) and lower serum IgG2a 
levels (Fig. S4 B). Although control-treated IL-25−/− mice 
displayed high worm burdens, inhibition of type 1 responses 
resulted in successful expulsion of Trichuris in IL-25−/− mice 
(Fig. 4 C). Contrary to the hypothesis that IL-25 is essential 
for type 2 responses, these results show that expression of 
IL-4, IL-5, and IL-13 was recovered in the absence of IL-25 
if endogenous type 1 cytokines were blocked. Therefore, 
these data show that the requirement for IL-25 in the devel-
opment of type 2 immunity is conditional and suggest that, 
in addition to promoting type 2 responses, IL-25 may func-
tion to actively inhibit expression of type 1 cytokines after 
helminth infection.
In support of an antiinfl  ammatory function of IL-25, we 
observed a critical role for this cytokine in limiting chronic 
infection-induced intestinal infl  ammation. Genetically sus-
ceptible strains of mice, such as AKR, as well as mice defi  -
cient in IL-4Rα signaling, develop persistent chronic 
infections but display moderate infection-induced infl  amma-
tion characterized by minimal crypt hyperplasia and no loss in 
gross tissue morphology (references 17, 21, 25 and unpub-
lished data). Although we observed no diff  erences in steady-
state intestinal structure between AKR, WT, or IL-25−/− 
mice (Fig. 5 A, top), chronically infected IL-25−/− mice de-
veloped severe intestinal infl   ammation characterized by a 
transmural infi  ltrate of lymphocytes, crypt elongation, dis-
rupted intestinal architecture, and a complete absence of 
  goblet cells (Fig. 5 A, bottom). Consistent with the hypo-
thesis that IL-25 may act to limit infl  ammation, the infection-
induced pathology in IL-25−/− mice was associated with 
heightened levels of the proinfl  ammatory cytokines IFN-γ 
and IL-17 in the mLN and cecum (Fig. 5, B and C). 
IL-10−/− mice also develop severe Trichuris-induced  intestinal 
infl  ammation that can be fatal (20). However, the destructive 
infl  ammation observed in IL-25−/− mice was not associated 
with defective expression of IL-10 in the mLN (Fig. 5 D), 
suggesting a novel IL-10–independent, IL-25–dependent 
pathway in the regulation of GI infl  ammation. Interestingly, 
mice defi  cient in NF-κB1 (p50) develop severe intestinal 
  infl  ammation after infection with Trichuris (19). IL-25 has 
been shown to activate NF-κB (12), suggesting that IL-25–
induced NF-κB1 activation may be a critical component in 
Figure 4.  Type 2 infl  ammation is IL-25 independent when endo  g-
enous type 1 responses are inhibited. Infected IL-25−/− mice were 
treated with anti–IL-12 and anti–IFN-γ every 4 d between days 4 
and 20. (A) Blockade of type 1 cytokines in infected IL-25−/− mice 
recovers TH2 cytokine responses. Antigen-specifi  c IL-4, IL-5, IL-13, and 
IFN-γ responses by restimulated mLN cells from control (Ig) or αIL-12/
αIFN-γ–treated (α12/γ) IL-25−/− mice determined by cytometric bead 
array (CBA; IL-4, IL-5, and IFNγ) or ELISA (IL-13). (B) Anti–IL-12/anti–
IFN-γ treatment recovers goblet cell responses in infected IL-25−/− 
mice. Goblet cell responses in the cecum of infected WT and control or 
αIL-12/αIFN-γ–treated IL-25−/− mice on day 20 after infection. Bar, 
50 μm. (C) IL-25 is dispensable for resistance to infection with Trichuris 
when type 1 responses are neutralized. Worm burdens in infected WT 
and control or αIL-12/αIFN-γ–treated IL-25−/− mice were determined 
at day 20 after infection. Results are presented as mean ± SEM and 
represent two independent experiments with three to four mice 
per group. *, P < 0.01.JEM VOL. 203, April 17, 2006  847
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ameliorating infl  ammation and maintaining the integrity of 
the mucosal barrier.
These results demonstrate that IL-25 plays a dual role in 
both the development of immunity and in limiting infl  am-
mation in the GI tract. As IL-25 is produced constitutively 
by T cells present in the CP of naive mice, this cytokine is 
most likely operating early after infection by driving expres-
sion of TH2 cytokines and simultaneously limiting the 
  production of proinfl  ammatory cytokines. Consistent with 
this, IL-25−/− mice fail to develop a polarized type 2   immune 
response and are unable to clear infection unless endogenous 
type 1 cytokine responses are blocked. This ability to limit 
proinfl  ammatory responses is critical, as chronically infected 
IL-25−/− mice develop severe intestinal pathology charac-
terized by high levels of IFN-γ and IL-17. IFN-γ and IL-17 
have been implicated in the pathogenesis of infl  ammatory 
bowel disease (26, 27). However, whether the intestinal 
  pathology observed in Trichuris-infected IL-25−/− mice is me-
diated by dysregulated IL-12–dependent, IFN-γ–producing 
TH1 cells or by an IL-23–dependent, IL-17–producing 
T cell population is still not known. It is possible that IL-25 
directly inhibits the production of IFN-γ or IL-17 from 
T cells, or alternatively limits their expression through infl  u-
encing expression of IL-12/IL-23. We observed no signifi  -
cant diff  erence in the expression levels of the mRNA for the 
IL-12 and IL-23 subunits p19, p35, and p40 between WT 
and IL-25−/− mice in the mLN after infection with Trichuris 
(unpublished data). Therefore, it is unclear at present how 
IL-25 is limiting infl  ammation.
Recent studies have shown that IL-17–producing CD4+ 
T cells mediate chronic infl  ammation in the central nervous 
system of animals that develop experimental autoimmune 
encephalitis (EAE), an animal model of multiple sclerosis 
that is characterized by chronic infl  ammatory responses and 
demyelination of neurons (28, 29). Supporting a role for 
IL-25 in limiting production of proinfl  ammatory cytokines 
and destructive tissue infl  ammation, IL-25−/− mice are highly 
susceptible to EAE, exhibiting reduced expression of TH2 
cytokines, increased numbers of IL-17pos CD4+ T cells in 
the central nervous system and rapid onset and severity of 
disease (unpublished data). Together with results presented 
here, these studies implicate IL-25 as a global inhibitor of 
chronic infl  ammatory responses. Therefore, manipulation 
of IL-25/IL-25R signaling off  ers the potential to promote or 
block type 2 responses associated with infection, asthma, or 
allergic infl  ammation and may provide a novel therapeutic 
approach for the treatment of multiple diseases associated 
with chronic infl  ammation.
MATERIALS AND METHODS
Animals, parasites, antigens, and infections. IL-25−/− mice were gen-
erated by homologous recombination (HR). After a screen of a C57BL/6J 
genomic BAC library (Genome Systems) with a full-length mIL-25 cDNA 
probe, a clone was identifi  ed and used to generate a shotgun plasmid library 
(SeqWright). Using a genomic subclone (F6), a BglII site was introduced in 
exon1 at the ATG via site-directed mutagenesis. This clone was digested 
with BglII and a 5,442-bp 5′ region of homology was cloned into the unique 
Figure 5.  IL-25 is required to limit infection-induced intestinal 
  infl  ammation. WT and IL-25−/− mice were infected with Trichuris and 
allowed to progress to the chronic phase of infection (day 30 after infection). 
(A) IL-25 is required to inhibit infection-induced pathology. Cecal sections 
from naive or infected (day 30) AKR, B6 WT, or IL-25−/− mice were stained 
with hematoxylin and eosin. Bar, 50 μm. (B and C) IL-25 limits expression of 
proinfl  ammatory cytokines in the draining mLN and gut after infection with 
Trichuris. (B) Increased Trichuris-specifi  c IFN-γ and IL-17 produced by mLN 
cells from WT or IL-25−/− mice at day 18 after infection as measured by CBA 
(IFN-γ) or ELISA (IL-17). White bars, medium; black bars, Trichuris antigen. 
(C) Expression of mRNA for IFN-γ and IL-17 in the mLN and cecum of WT 
and IL-25−/− mice at day 30 after infection. (D) IL-10 expression in the mLN 
is intact in infected IL-25−/− mice. mLN cells from WT or IL-25−/− mice at 
day 18 after infection were restimulated with (black bars) or without (white 
bars) Trichuris antigen and IL-10 levels were determined by CBA. IL-10 mRNA 
levels in the mLN at day 30 after infection were determined by real-time PCR. 
Results are presented as mean ± SEM and represent three independent 
  experiments with three to four mice per group. ND, not detected.848  IL-25 REGULATES TYPE 2 IMMUNITY AND INFLAMMATION | Owyang et al.
BglII site of pbgal-Basic (CLONTECH Laboratories, Inc.). A 1,049-bp 3′ 
region of homology was generated by PCR using a genomic subclone (C6), 
incorporating unique SpeI and NotI restriction sites, and cloned into pBS-
lox-Neo-lox. This plasmid was digested with SalI and the lox-Neo-lox-3′ 
region of homology was ligated into the unique SalI site of the 5′ arm-pbgal-
Basic, yielding the fi  nal targeting vector. The NheI linearized targeting vec-
tor was electroporated into C57BL/6 ES cells and Neo-resistant clones were 
analyzed for HR using a PCR based screening strategy followed by South-
ern blot confi  rmation with 5′ and 3′ probes. A confi  rmed HR clone was 
electroporated with a Cre recombinase expression containing plasmid and 
several Neo-sensitive clones were screened using Southern blot to identify 
the Neo-fl   ipped HR IL-25-LacZ ES line. This line was injected into 
C57BL/6 blastocysts and IL-25-LacZ-knockin (KI)−/− progeny were ob-
tained by intercrossing IL-25–LacZ-KI+/− animals. A PCR-based genotyp-
ing strategy was developed to track the IL-25 WT and KI alleles as follows: 
IL-25 targeted allele, sense 5′-G  C  T  G  A  C  T  C  T  C  A  A  C  A  T  T  C  T  A  C  T  C  C 
T  C  C  -3′, antisense 5′-C  C  T  G  C  T  G  C  T  T  C  A  G  G  T  A  G  G  G  C  T  T  T  G  -3′; wild-
type IL-25 allele, sense 5′-C  T  A  C  A  G  A  C  A  G  G  C  T  C  C  C  A  C  A  T  G  G  A  C  C  -3′, 
antisense 5′-C  C  T  G  C  T  G  C  T  T  C  A  G  G  T  A  G  G  G  C  T  T  T  G  -3′.
C57BL/6J, AKR, SCID (CBySmn.CB17-Prkdcscid/J), and RAG−/− 
(B6.129S7-Rag1tm1Mom/J) mice were obtained from The Jackson Laboratory. 
Animals were maintained in a specifi  c-pathogen free environment and tested 
negative for pathogens in routine screening. All experiments were performed 
following the guidelines of the University of Pennsylvania Institutional 
  Animal Care and Use Committee. Trichuris muris was maintained in genetically 
susceptible animals. Isolation of Trichuris excretory-secretory antigen and 
eggs was performed as described previously (14). Mice were infected on day 
0 with 150–200 embryonated eggs, and parasite burdens were assessed on 
various days after infection.
Cytokines and monoclonal antibodies. Monoclonal antibodies against 
IL-12 (C17.8) and IFN-γ (XMG-6) were purifi  ed from ascites by ammo-
nium sulfate precipitation and extensively dialyzed against PBS. Mice were 
treated i.p. with 500 μg of each antibody every 4 d between days 4 and 20 
after infection. rIL-25 was synthesized and purifi  ed as described previously 
(11). Mice were treated i.p. with 10 μg of rIL-25 every other day between 
days 8 and 18 after infection.
mRNA analysis. mRNA expression levels were analyzed using real-time 
PCR. Total RNA from tissue was isolated, cDNA was prepared, and 10–25 ng 
of cDNA was used to analyze gene expression in either the SYBR green 
real-time PCR assay or using predesigned TaqMan probe sets for IL-25, 
IL-25R, IL-4, IL-13, IL-10, IL-17, IFN-γ, ubiquitin, and β-actin (Applied 
Biosystems). Reactions were run on the GeneAmp 5700 Sequence Detec-
tion System (Applied Biosystems), and expression was normalized to the 
housekeeping genes ubiquitin or β-actin.
Cell culture and cytokine and lacZ analysis. At necropsy, the mesen-
teric LN was harvested, and single cell suspensions were prepared in DMEM 
supplemented with 10% heat-inactivated FBS, 2 mM glutamine, 100 U/ml 
penicillin, 100 μg/ml streptomycin, 25 mM Hepes, and 5 × 10−5 M 2-ME. 
Cells were plated in medium alone or in the presence of Trichuris muris ES 
Ag (50 μg/ml). Cell-free supernatants were harvested after 48 h, and ana-
lyzed for cytokine secretion by sandwich ELISA or cytometric bead array 
(mouse Th1/Th2 cytokine CBA; BD Biosciences). For determination of 
lacZ expression, the fl  uorescent β-galactosidase substrate fl  uorescein di-β-d-
galactopyranoside (FDG; Invitrogen) was added to cells isolated from the 
mLN or CP of naive or infected IL-25−/− mice that express lacZ in place of 
IL-25. After 20 min on ice, cells were surface stained with fl  uorescently la-
beled antibodies against CD4, CD8, CCR3, CD11b, CD11c, CD19, FcεRI, 
and NK1.1 (eBioscience) and analyzed by fl  ow cytometry on a FACSCalibur 
using CELLQuest Pro software (BD Biosciences).
Serum immunoglobulin analysis. Serum was analyzed by ELISA for 
Trichuris-specifi  c IgG1 and IgG2a as described previously (19). Total serum IgE 
was analyzed with an OptEIA IgE ELISA kit following the manufacturer’s 
recommendations (BD Biosciences).
Goblet cell, RELM𝗃, and mucosal mast cell responses. Segments of 
cecum were removed and fi  xed in 4% paraformaldehyde. For detection of 
intestinal goblet cells, 5-μm paraffi   n-embedded sections were cut and stained 
with Alcian blue-periodic acid Schiff  ’s reagent or with hematoxylin and 
  eosin. Isolation of proteins from stool samples was performed as described 
previously (15). Equal amounts of protein were analyzed by SDS-PAGE and 
immunoblotted for RELMβ with a polyclonal rabbit α-murine RELMβ 
antibody. Intestinal mast cells were identifi   ed by immunohistochemistry 
  using rat anti–mouse mast cell protease-1 (mMCP-1) antibody as described 
previously (30). Concentrations of mMCP-1 in serum were quantitated as 
described previously (30).
Statistics. Results represent the mean ± SEM unless otherwise stated. 
  Statistical signifi  cance was determined by Student’s t test.
Online supplemental material. Trichuris-specifi  c serum IgG2a response in 
AKR mice after infection with Trichuris with or without exogenous rIL-25 
is shown in Fig. S1. Fig. S2 depicts the serum immunoglobulin responses 
(IgG1, IgG2a, and IgE) of wild-type and IL-25−/− mice after infection with 
Trichuris. Fig. S3 shows the local and systemic mucosal mast cell responses in 
wild-type and IL-25−/− mice after infection with Trichuris. Fig. S4 shows that 
blocking IL-12 and IFN-γ in IL-25−/− mice after infection with Trichuris 
results in decreased serum IgG2a and increased IgG1 and IgE responses. 
Online supplemental material is available at http://www.jem. org/cgi/content/
full/jem.20051496/DC1.
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